Lawrence E. Leibowitz - Aug 16, 2023 Form 4 Insider Report for Enfusion, Inc. (ENFN)

Role
Director
Signature
/s/ Matthew Campobasso, as Attorney-in-Fact
Stock symbol
ENFN
Transactions as of
Aug 16, 2023
Transactions value $
$0
Form type
4
Date filed
8/18/2023, 04:15 PM
Previous filing
Aug 15, 2023
Next filing
Nov 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENFN Class A Common Stock Award $0 +10.4K +7.12% $0.00 156K Aug 16, 2023 Direct F1
transaction ENFN Class A Common Stock Award $0 +6.34K +4.07% $0.00 162K Aug 17, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of fully vested shares issued under the Enfusion, Inc. 2021 Stock Option and Incentive Plan in connection with the previously disclosed pre-IPO termination of the Enfusion Ltd. LLC Change in Control Bonus Plan.